CSII : Analysis & Opinions
April 29, 2013Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
November 21, 2011Covidien is overlooked and undervalued.
August 3, 2011Find out why Covidien is much better than many investors assume.
June 1, 2010Covidien made a surprising deal to get into peripheral vascular therapies - a business with big growth potential.